The Board of Directors of Sailong Pharmaceutical Group Co., Ltd. announced a change in its legal representative. The position will transition from Vice Chairman and President Chen Ke to Chairman Zhang Guangyang. This change was approved at the 26th meeting of the Fourth Board of Directors. The company will handle the necessary industrial and commercial registration changes.
Summary generated by AI · Always verify with source document
Securities Code: 002898 Securities Abbreviation: *ST Sailong Announcement No.: 2026-064
Sailong Pharmaceutical Group Co., Ltd. Announcement on the Change of the Company's Legal Representative
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.